His radical approach transforms the life of Matt Baszucki, whose dramatic recovery from severe mental illness inspires his mother Jan to launch the Baszucki Group, funding clinical trials that could rewrite psychiatric treatment. Pushing back against skeptical colleagues and entrenched medical dogma, Palmer must prove that diet and metabolism hold the key to mental health, a discovery that could offer hope to millions trapped in cycles of failed medications and endless suffering.

We follow scientists like Dr. Ruth Itzhaki, who first identified the link between the herpes virus and Alzheimer’s in the 1980s. Though her viral hypothesis-based work was ignored for decades, it laid the foundation for a groundbreaking clinical trial now underway at Columbia University, led by Dr. Davangere Devanand, investigating whether the antiviral drug valacyclovir can slow disease progression. Meanwhile, Prof. David Attwell in the UK explores repurposing drugs that target blood flow to indirectly target amyloid. Beyond pharmaceuticals, neuroscientist Li-Huei Tsai has  discovered the power of non-invasive sensory stimulation using light and sound for slowing disease progression. However, to make life changing progress, these scientists first must fight for the funding that often favors amyloid therapies.

Aliquam a metus pharetra, porta ex sed, bibendum ex. Nullam lorem justo, cursus at facilisis id, feugiat sit amet urna. Maecenas vitae finibus enim, non malesuada nisl. Vestibulum non risus erat. Pellentesque at odio sit amet lorem dapibus accumsan.  Quisque ultricies vitae enim at pulvinar. Fusce dignissim, dui vitae facilisis pulvinar, justo nisl laoreet dolor, quis volutpat neque augue sed nulla. Cras ornare porta tellus id feugiat.